Back
Neovasc 10K Form
Sell
49
NVCN
Neovasc
Last Price:
29.16
Seasonality Move:
-15.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVCN News And Ratings
See the #1 stock for the next 7 days that we like better than NVCN
NVCN Financial Statistics
Sales & Book Value
| Annual Sales: | $2.55M |
|---|---|
| Cash Flow: | $-6.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.22 |
| Price / Book: | 2.85 |
Profitability
| EPS (TTM): | -12.41000 |
|---|---|
| Net Income (TTM): | $-33.52M |
| Gross Margin: | $1.99M |
| Return on Equity: | -77.15% |
| Return on Assets: | -56.82% |
Neovasc Earnings Forecast
Key Neovasc Financial Ratios
- The Gross Profit Margin over the past 21 years for NVCN is 78.04%.
- The Selling, General & Administrative Expenses for NVCN have been equal to 610.20% of Gross Profit Margin.
- The Research & Development expenses have been 605.88% of Revenue.
- The Interest Expense is -2.53% of Operating Income.
- The Net Earning history of NVCN is -976.08% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 11 years.
Neovasc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Medical Devices |
| Sector: | Healthcare |
| Current Symbol: | NVCN |
| CUSIP: | 64065J |
| Website: | neovasc.com |
Debt
| Debt-to-Equity Ratio: | 0.44 |
|---|---|
| Current Ratio: | 8.44 |
| Quick Ratio: | 8.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |